BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25194736)

  • 21. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient induction of pluripotent stem cells from menstrual blood.
    Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
    Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.
    Li W; Zhou H; Abujarour R; Zhu S; Young Joo J; Lin T; Hao E; Schöler HR; Hayek A; Ding S
    Stem Cells; 2009 Dec; 27(12):2992-3000. PubMed ID: 19839055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of induced pluripotent stem cells from neonatal mouse cochlear cells.
    Du D; Lou X
    Differentiation; 2014; 87(3-4):127-33. PubMed ID: 24582575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.
    Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM
    Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
    Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
    Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of mouse-induced pluripotent stem cells with plasmid vectors.
    Okita K; Hong H; Takahashi K; Yamanaka S
    Nat Protoc; 2010 Mar; 5(3):418-28. PubMed ID: 20203661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
    Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
    Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Takahashi K; Tanabe K; Ohnuki M; Narita M; Ichisaka T; Tomoda K; Yamanaka S
    Cell; 2007 Nov; 131(5):861-72. PubMed ID: 18035408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells generated without viral integration.
    Stadtfeld M; Nagaya M; Utikal J; Weir G; Hochedlinger K
    Science; 2008 Nov; 322(5903):945-9. PubMed ID: 18818365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation.
    Schmidt R; Plath K
    Genome Biol; 2012 Oct; 13(10):251. PubMed ID: 23088445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
    Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
    Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming of murine and human somatic cells using a single polycistronic vector.
    Carey BW; Markoulaki S; Hanna J; Saha K; Gao Q; Mitalipova M; Jaenisch R
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):157-62. PubMed ID: 19109433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.